Human IGFBP-7 ELISA Kit

$245.00 – $350.00

Related Target	IGFBP7
Species	human
Sample Type	Serum, plasma, cell culture supernatant, and other biological samples
Sample Volume	100 μL (diluent)
Sensitivity	4.67 pg/mL
Array Range	62.5 pg/mL – 4000 pg/mL
Assay Time	3.5 h
Recovery	85% – 112%
Average Recovery	104%

ELISA Kit Detail Information

Related Target	IGFBP7
Species	human
Sample Type	Serum, plasma, cell culture supernatant, and other biological samples
Sample Volume	100 μL (diluent)
Sensitivity	4.67 pg/mL
Array Range	62.5 pg/mL – 4000 pg/mL
Assay Time	3.5 h
Recovery	85% – 112%
Average Recovery	104%
Intra Precision	2.0% – 3.2%
Inter Precision	2.4% - 3.2%
Plate	Detachable 96-well plate
Storage	If the reagent kit is unopened, it should be stored at 4℃. However, if it has been opened, the standard solution should be stored at -20℃, while the other components should be stored at 4℃.
Delivery	4℃ blue ice transportation
Components	96-well polystyrene enzyme-linked immunosorbent assay (ELISA) plate coated with anti-IGFBP-7 monoclonal antibody Human IGFBP-7 freeze-dried standard IGFBP-7 detect Antibody Standard Diluent Assay Buffer(10×) Substrate TMB Stop Solution Washing Buffer(22×) Sealing Film
Assay Principle	This kit utilizes the double antibody sandwich enzyme-linked immunosorbent assay (ELISA) detection technique.Specific anti-human IGFBP-7 antibodies are precoated on a high-affinity ELISA plate. Standard samples, test samples, and the detection antibody labeled with horseradish peroxidase are added to the wells of the ELISA plate. After incubation, IGFBP-7 present in the samples binds to the solid-phase antibodies and the detection antibodies. After washing, a colorimetric substrate, TMB, is added and the plate is incubated in the dark for color development. The intensity of the color reaction is directly proportional to the concentration of IGFBP-7 in the samples.A stop solution is added to terminate the reaction, and the absorbance value is measured at a wavelength of 450 nm (with a reference wavelength range of 570-630 nm).

Related Targets

IGFBP7

IGFBP7 Target Infomation Overview

Target Symbol: IGFBP7, insulin like growth factor binding protein 7
Gene Groups: I-set domain containing
Alias: MAC25; IGFBP-7; PSF; FSTL2
Alias Names: insulin-like growth factor binding protein 7

IGFBP7, insulin like growth factor binding protein 7 Target Infomation by Species

Human
Mouse
Rat

Human IGFBP7 Target Information

Target Symbol: IGFBP7, insulin like growth factor binding protein 7
Alias:
- AGM
- angiomodulin
- FSTL2
- IBP-7
- IGF-binding protein 7
- IGFBP-7
- IGFBP-7v
- IGFBP-rP1
- IGFBPRP1
- insulin-like growth factor binding protein 7
- insulin-like growth factor-binding protein 7
- MAC25
- PGI2-stimulating factor
- prostacyclin-stimulating factor
- PSF
- RAMSVPS
- TAF
- tumor-derived adhesion factor
NCBI_Gene: 3490
UniProtKB: Q16270

Human IGFBP7 Predicted Functions

Predicted to enable insulin-like growth factor binding activity. Predicted to be an extracellular matrix structural constituent. Involved in cell adhesion. Located in extracellular exosome. Colocalizes with collagen-containing extracellular matrix.

Mouse Igfbp7 Target Information

Target Symbol: Igfbp7, insulin-like growth factor binding protein 7
Alias:
- AGM
- follistatin-like 2
- Fstl2
- mac25
NCBI_Gene: 29817

Mouse Igfbp7 Predicted Functions

Predicted to enable insulin-like growth factor binding activity. Predicted to be an extracellular matrix structural constituent. Acts upstream of or within inner ear development. Located in collagen-containing extracellular matrix and extracellular space. Is expressed in several structures, including alimentary system; brain; cardiovascular system; eye; and genitourinary system. Orthologous to human IGFBP7 (insulin like growth factor binding protein 7).

Rat Igfbp7 Target Information

Target Symbol: Igfbp7, insulin-like growth factor binding protein 7
Alias:
- insulin-like growth factor-binding protein 7
- LOC289560
NCBI_Gene: 289560
- UniprotKB: F1M9B2
- UniprotKB: Q5RJM3

Rat Igfbp7 Predicted Functions

Predicted to enable insulin-like growth factor binding activity. Involved in several processes, including embryo implantation; response to cortisol; and response to retinoic acid. Located in extracellular space. Biomarker of renal cell carcinoma. Orthologous to human IGFBP7 (insulin like growth factor binding protein 7).

Citations for Human IGFBP-7 ELISA Kit

There are no citations for this product yet.

If you buy this product and mention it in your thesis, we welcome you to provide us with the thesis information. As a thank you, we will give you some gifts, such as discount coupons.

Citations data is updating...

Competitive ELISA: Principles, Methods, and Key Differences

Competitive ELISA is a widely used immunoassay technique for quantifying target analytes in samples by measuring their interference with a known signal. This method is based on the principle of limited antibodies, where the target analyte competes with a labeled antigen for antibody binding. Competitive ELISA is commonly used for detecting small molecules with fewer epitopes and is available in direct and indirect formats. This article explains the fundamental principles, experimental workflow, and key differences between direct and indirect competitive ELISA, helping researchers choose the optimal method for their applications.

ELISA (Enzyme-Linked Immunosorbent Assay): Principle, Types, and Step-by-Step Protocol

Learn about ELISA (Enzyme-Linked Immunosorbent Assay), a highly sensitive immunoassay technique used in medical diagnostics and biopharmaceuticals. This guide covers its principles, common types (sandwich, direct, indirect, competitive), detailed protocol, and key considerations for accurate results.

ELISA Blood Samples: Serum vs Plasma - Key Differences, Preparation & Hemolysis Effects

Learn whether to use serum or plasma for ELISA testing, including preparation protocols, key differences (fibrinogen, clotting factors), and how hemolysis impacts results. Essential guide for accurate immunoassays.